“As cases continue to rise across the country, Kenyan scientists in the beachside destination of KIlifi are hard at work on the country’s first COVID-19 vaccine trial. On Oct. 30, Kenya Medical Research Institute Wellcome Trust, which is leading the study, launched a phase one trial of the Oxford Astrazeneca vaccine candidate.”